Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 69 (1) , 13-19
Abstract
To investigate the predictive ability of serum matrix metalloproteinase-9 (MMP-9) in the acute phase of Kawasaki disease (KD) with coronary artery lesions (CALs). Patients with KD hospitalized in Lanzhou University Second Hospital, Northwest China, from November 2015 to January 2018 were retrospectively reviewed, and clinical trial indicators and peripheral blood specimens were collected before intravenous immunoglobulin therapy treatment. The independent risk factors were determined using multivariate regression analysis. The net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were used to quantitatively evaluate the ability of MMP-9 to improve the efficiency of predicting KD with CALs. The white cell, neutrophil percentage, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were higher in patients with higher MMP-9, and the monocyte percentage was higher in patients with lower MMP-9. Logistic regression analysis revealed that long-term fever; elevated CRP, ESR, platelets (PLT), and MMP-9; and low albumin (ALB) levels were independent predictors of KD with CALs. A predictive model of KD with CALs using fever duration, CRP, ESR, PLT, and ALB showed significantly improved predictive ability when MMP-9 was added to the model (the area under the curve increased by 0.02; no change in sensitivity; specificity increased from 81.48% to 87.04%; NRI value: 13.46%; IDI value: 5.00%, p<0.05). Adding MMP-9 to traditional risk factors may improve prediction of CALs, the overall predictive ability of model 2 was increased by 5%.Keywords
Funding Information
- Natural Science Foundation of Gansu Province (18JR3RA323)
This publication has 40 references indexed in Scilit:
- Net Reclassification Improvement and Integrated Discrimination ImprovementCirculation: Cardiovascular Imaging, 2013
- Matrix Metalloproteinase-9 Genotype as a Potential Genetic Marker for Abdominal Aortic AneurysmCirculation: Cardiovascular Genetics, 2012
- Prevalence and the Long-term Coronary Risks of Patients With Kawasaki Disease in a General Population <40 YearsCirculation: Cardiovascular Quality and Outcomes, 2012
- Pathogenesis of Kawasaki diseaseClinical and Experimental Immunology, 2011
- Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki diseaseClinical and Experimental Immunology, 2009
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- The Limitations of Risk Factors as Prognostic ToolsNew England Journal of Medicine, 2006
- Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and DeathNew England Journal of Medicine, 2006
- Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki diseasePediatrics International, 2005
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening MarkerAmerican Journal of Epidemiology, 2004